Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Polaprezinc |
EINECS | 600-848-7 |
CAS No. | 107667-60-7 | Density | N/A |
PSA | 101.31000 | LogP | -0.39430 |
Solubility | N/A | Melting Point |
300 ºC |
Formula | C9H12N4O3Zn | Boiling Point | 557.6oC at 760 mmHg |
Molecular Weight | 289.609 | Flash Point | 291oC |
Transport Information | N/A | Appearance | White to pale-yellow crystalline solid |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Zinc,[N-b-alanyl-L-histidinato(2-)-N,NN,Oa]-;L-Histidine, N-b-alanyl-, zinc complex;Promac;Promac (antiulcer agent);Z 103;Zinc L-carnosine;b-Alanyl-L-histidinato zinc; |
Article Data | 2 |
IUPAC Name: Zinc(2R)-2-[(3-amino-1-oxidopropylidene)amino]-3-(1H-imidazol-5-yl)propanoate
The MF of Polaprezinc (CAS NO.107667-60-7) is C9H12N4O3Zn.
The MW of Polaprezinc (CAS NO.107667-60-7) is 289.62558.
Synonyms of Polaprezinc (CAS NO.107667-60-7): Histidine, beta-alanyl-, zinc salt ; zinc 2-(beta-Alanylamino)-3-(imidazol-3-id-4-yl)propanoate ; Zinc carnosine
Product Categories: Intermediates & Fine Chemicals;Pharmaceuticals
Apperance: White To Pale-Yellow Crystalline Solid
Melting Point: >300 °C
Polaprezinc (CAS NO.107667-60-7) is used as A novel anti-gastric ulcer agent and a new dietary supplement approved by the federal agency.
1. | orl-rat LD50:7375 mg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 41 (1991),1033. | ||
2. | ipr-rat LD50:405 mg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 41 (1991),1033. | ||
3. | scu-rat LD50:>5 g/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 41 (1991),1033. | ||
4. | orl-mus LD50:1269 mg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 41 (1991),1033. | ||
5. | ipr-mus LD50:165 mg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 41 (1991),1033. | ||
6. | scu-mus LD50:758 mg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 41 (1991),1033. | ||
7. | orl-dog LD:>200 mg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 45 (1995),52. | ||
8. | orl-mky LD:>626 mg/kg | ARZNAD Arzneimittel-Forschung. Drug Research. 43 (1993),562. |
A poison by intraperitoneal route. Moderately toxic by ingestion and subcutaneous routes. An experimental teratogen. Other experimental reproductive effects. When heated to decomposition it emits toxic vapors of NOx and Zn.